4th Anti-Infectives Partnering & Deal-Making Summit
|Event Date/Time: Jan 25, 2007||End Date/Time: Jan 26, 2007|
|Abstract Submission Date: Dec 25, 2006|
The Summit brings together a broad audience of representatives from government, industry and academia to participate in technical and business discussions. The sessions will provide a meaningful backdrop for useful discussion and cross-pollination of ideas.
We have designed the conference to provide both a high level view of the industry as well as dive “deep” into specific product opportunities and challenges. The conference will cover the different models for partnering (co-promote rights in partnerships, takeovers), big pharma spin offs into stand-alone biotech companies, re-emerging pathogens (MRSA community acquired, C. difficile), anti-fungals (anidulafungin, inhaled mmphotericin, hepatitis C, RSV, rhinovirus), bioshield, and the future partnering in infectious diseases, (biologics role in ID, the future of cepsis, non-government money to address unmet medical needs).
We hope to see you and your colleagues this January in San Francisco.